Increase text size: A A A

Type in the condition you need,
or visit Advanced Search

Print this page

Email this to a friend

Comment on this page

Save to my Health Library

Johns Hopkins Health Alert

Refining What PSA Levels Mean

In this excerpt from a recent issue of Health After 50, H. Ballentine Carter, M.D., Professor of Medicine at the Johns Hopkins Hospital, discusses current trends in PSA testing.

Since the prostate specific antigen (PSA) test became widely used in the 1990s, prostate cancer deaths have dropped dramatically. Today one of the biggest problems with PSA testing is that it detects many cancers that are not life threatening and would never have been diagnosed or treated otherwise, especially among older men.

Q. How does PSA testing result in overdiagnosis?

Dr. Carter: PSA levels are most often elevated for reasons other than cancer, such as prostatic enlargement (benign prostatic hyperplasia -- BPH) or prostatic inflammation, which are common among aging men. In addition, many men with these conditions also have small prostate cancers that are also common with age but usually do not progress.

The PSA test cannot differentiate between dangerous cancer and benign conditions, so when biopsies are based on elevated PSA test results, prostate cancers are often found serendipitously; many of these would not have been found otherwise. This over diagnosis of prostate cancer has been estimated to occur in 30–50% of men between ages 55 and 80 years. Over 85% of prostate cancers detected are treated when diagnosed. Thus, over treatment of cancers that would not have caused harm is a byproduct of screening.

The extent to which PSA testing for the early diagnosis of prostate cancer results in more benefit (reduction of prostate cancer deaths) versus harm (detection and treatment of prostate cancers that would not have caused harm) is hotly debated. Nevertheless, physicians and patients prefer the risk of unnecessary treatment to missing a potentially lethal cancer. The solution to the dilemma is a test that can differentiate between life- threatening and indolent prostate cancer before a biopsy takes place.

Q. In the meantime, how are doctors trying to reduce the number of needle biopsies and over diagnosis?

Dr. Carter: Currently, annual PSA testing beginning at age 50 is recommended, but newer guidelines will stress the need for a baseline PSA test at age 40, another one at 45, and then an annual or biennial PSA test beginning at age 50 depending on the PSA level. By starting to accumulate a PSA history at age 40, a man will have measurements to compare with levels obtained in his 50s in order to determine the rate his PSA changed -- his PSA velocity—a useful measure of the presence of a life-threatening cancer.

PSA levels vary a lot over the short term (6 months). It is important to have a PSA history of more than two years to evaluate PSA velocity accurately. If PSA velocity is consistently above 0.4 ng/mL per year in a man with a PSA level below 4.0 ng/mL, prostate cancer should be suspected and a biopsy considered. In men with PSA levels between 4 and 10 ng/mL, a PSA velocity of 0.75 ng/mL per year suggests the presence of prostate cancer.

Posted in Prostate Disorders on June 19, 2008
Reviewed July 2009

Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Your email address:

Comments

Post a Comment

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or MediZine LLC, which has no responsibility for any comments posted on this site.


I am a 68 year old male who was diagnosed with a "boggy prostate" starting in my mid 30s. I started having PSA tests run in 1992. Only one time (7-1995) have I had a level below 4.0 w/o medication. I have had three negative biopsies in the last 14 years. I have had numerous prostate infections since my 30s. However since being on Proscar and it's generic, I have not had an infection in 2 years. There needs to be a better test for those like my self that suffer from prostatic enlargement (benign prostatic hyperplasia -- BPH) and/or chronic prostatic inflammation.

Posted by: dlemon | June 21, 2008

The article was interesting. But I thought I recently read something similar. So went to my Prostate file and Voila.I was right. In october 2007 the Johns Hopkins Health After 50 monthly magazine had verbatim the same article entitled Prostate Screening: Refining What PSA Levels Mean. So I ask: why was an eight month old article recycled in June of 2008?.

I was under the impression that Johns Hopkins was always on the cusp of health information. I'd appreciate a reply.

Thanks. DD

Posted by: dd | June 21, 2008

DD: You're right -- this article was excerped from an earlier Health After 50 article. We felt the information would be of great value to a wider audience, many of whom did not have the chance to read it in the newsletter -- which is why we used it as a Health Alert. And by the way, the informaton is still quite timely. Editor

Posted by: Marjorie | June 23, 2008

I've read about a new test that was developed at John Hopkins to not only detect early prostate cancers but also how aggressive they are. It is called EPCA-2. What is the status of this test? Is it in clinical trials? If so, where and how would one enroll in a trial?

Posted by: JM211 | July 6, 2008

The EPCA test information is here at the site: EPCA-2 Test Article

and at the bottom of the page is all the contact information you need to find out more about enrolling in the trial.

Posted by: Jo | July 30, 2008

My husband was diagnosed with prostate cancer,which had gone into some of his bones. His PSA level was extremely high at the time. He started taking treatments and his PSA went down drastically.He was also taking CASADEX. After awhile on the CASADEX his PSA went up. His doctor took him off the CASADEX,and the PSA went back down. It started going back up again,so he was put back on the CASADEX....now it us going back up. How high does his PSA have to get before we should really start worrying? Has this type of cancer ever been cured?

Posted by: dolphin | February 9, 2009

I have some serious reservations about Johns Hopkins and the information it disseminates about prostate cancer.

If I were to have listened to the information offered in your White Paper, I would have subjected myself to needless biopsy. As it is, there is enough hysteria in the field. You folks seems to be selling surgery at every turn.

My urologist called me in hysterics one night telling me based on my PSA (3.9, Free PSA 17%) I was at 25% risk of prostate cancer. He allowed that he would be happy to biopsy and if so much as one cancer cell was found he could do a radical prostatectomy and have me "home the next day." "Wow", I asked... "you mean you can have me home, incontinent and impotent the very next day?" He failed to see my sarcasm and issued another warning about how I was burying my head in the sand.

In reality I was suffering from prostatitis which was cured with a course of Levaquin and elimination of spicy food and alcohol. Indeed a graph I keep shows my free PSA has been in the same range +/- for the last ten years. There was no PSA velocity, and he should have known that. Needless to say I stopped seeing this doctor. But he, like so many others, is maiming men just like women were maimed years ago with needless mastectomies.

It would behoove you to remind your readers in each and every article that prostate cancer is common, the deadly form is not, the rate of growth is usually slow and most men will die with prostate cancer not from it.

Oh, lo and behold, 2 years after that hysterical call from the doctor who could not wait to do a biopsy, at age 60 my last PSA was 2.7 and free PSA was 25%. All quite normal given my history.

If you are going to provide information of people provide ALL of it and avoid fanning the flames of hysteria.

Posted by: teddavid | May 9, 2009

I have some serious reservations about Johns Hopkins and the information it disseminates about prostate cancer.

If I were to have listened to the information offered in your White Paper, I would have subjected myself to needless biopsy. As it is, there is enough hysteria in the field. You folks seems to be selling surgery at every turn.

My urologist called me in hysterics one night telling me based on my PSA (3.9, Free PSA 17%) I was at 25% risk of prostate cancer. He allowed that he would be happy to biopsy and if so much as one cancer cell was found he could do a radical prostatectomy and have me "home the next day." "Wow", I asked... "you mean you can have me home, incontinent and impotent the very next day?" He failed to see my sarcasm and issued another warning about how I was burying my head in the sand.

In reality I was suffering from prostatitis which was cured with a course of Levaquin and elimination of spicy food and alcohol. Indeed a graph I keep shows my free PSA has been in the same range +/- for the last ten years. There was no PSA velocity, and he should have known that. Needless to say I stopped seeing this doctor. But he, like so many others, is maiming men just like women were maimed years ago with needless mastectomies.

It would behoove you to remind your readers in each and every article that prostate cancer is common, the deadly form is not, the rate of growth is usually slow and most men will die with prostate cancer not from it.

Oh, lo and behold, 2 years after that hysterical call from the doctor who could not wait to do a biopsy, at age 60 my last PSA was 2.7 and free PSA was 25%. All quite normal given my history.

If you are going to provide information of people provide ALL of it and avoid fanning the flames of hysteria.

Posted by: teddavid | May 9, 2009



Post a Comment


New to the Johns Hopkins Health Alerts?
Signup

User Name:


This appears next to your comment.


Email Address:

(this will not be posted)
This will be your login ID.

Password:

Confirm Password:


Receive Health Alerts?

Notify me when new comments are posted?

Comment (offensive materials and/or spam will be removed, no HTML allowed)

Already a subscriber?
Login

Email:

Password:


Forgot your password?

(800) 829-0422

Registered Users Log-in:

Email:

Password:

Remember me
Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being A Registered User

Health Topic Pages

Arthritis +Add
Back Pain & Osteoporosis +Add
Cancer
Caregivers | Caregiving
Colon Cancer +Add
Complementary Medicine
Depression & Anxiety +Add
Diabetes +Add
Digestive Health +Add
Enlarged Prostate +Add
Exercise and Fitness
Healthy Living +Add
Heart Health +Add
Hypertension & Stroke +Add
Lung Disorders +Add
Memory +Add
Men's Health
Nutrition +Add
Prescription Drugs +Add
Prostate Disorders +Add
Sexual Health
Vision +Add
Weight Control +Add
Women's Health
Health Alert Special Report


Johns Hopkins' Bestsellers

Prostate Disorders

Our Featured Title:

The Johns Hopkins Prostate Bulletin Cover

The Johns Hopkins Prostate Bulletin
The Johns Hopkins Prostate Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:

  • Special Report #1: BPH (Benign Prostatic Hyperplasia)
  • Special Report #2: Diet and Prostate Health
  • Special Report #3: Treating Overactive Bladder
  • Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
  • Special Report #5: The Radical Prostatectomy

Click here to read more or order The Johns Hopkins Prostate Bulletin.


Related Titles:

  • ALL NEW! The Johns Hopkins Prostate Disorders White Paper 2009
    Features Prostate Cancer, BPH (enlarged prostate), PSA testing, and much more.
    PLUS, get your special discount and FREE Special Report: Prostate Power through this exclusive web-only offer.
    Read more or order the INSTANT PDF DOWNLOAD EDITION
    Read more or order the PRINT EDITION


    THE JOHNS HOPKINS PROSTATE LIBRARY

    A series of cutting-edge publications designed to address your specific prostate questions.


  • ALL NEW!Number One of America's Best Hospitals 2009: Johns Hopkins

    The Johns Hopkins Hospital has been ranked #1 again in the Honor Roll of America's Best Hospitals by
    U.S. News and World Report for the 19th consecutive year.


    Please visit here for more information about Johns Hopkins Patient Services


    Medical Disclaimer: The information on thispage is not intended to substitute for the advice of a physician.


    Charter Subscription to The Johns Hopkins Prostate Bulletin

    PLUS 5 FREE Special Reports, available right now as INSTANT PDF DOWNLOADS

    The Johns Hopkins Prostate Bulletin

    The Johns Hopkins Prostate Bulletin brings you up-to-the-minute information about the latest advances in prostate medicine, from the very experts at the forefront of life-saving discoveries in this vital field. From prostate cancer, and prostate surgery and common side effects such as erectile dysfunction and incontinence, to prostatitis, to Benign Prostatic Hyperplasia (BPH) to Prostate Cancer, The Johns Hopkins Prostate Bulletin provides the most cutting–edge information for men (and their loved ones!) facing these health challenges. It's like having an in-depth consultation from a specialist from America's #1 medical center.

    ADDED BONUS: FREE SPECIAL REPORTS!

    Click here for details:

    Prostate Cancer Information Yes! Enter my charter subscription to The Johns Hopkins PROSTATE BULLETIN on a risk-FREE basis at the charter subscription rate of $149 for one year (4 quarterly issues)—that's a discount of $46 off the regular subscription price thanks to this web-only offer.

    TO ACCEPT THIS RISK-FREE OFFER,
    simply fill out the form and click "Submit my order."

    First Name

    Last Name

    Address

    Address2

    City

    State

    Zip

    Email Address (required)


    CANADIAN ORDERS, click here
    INTERNATIONAL ORDERS, click here


    Please send me my FREE Johns Hopkins Prostate Health Alerts via email.


    What you will get with your subscription to The Johns Hopkins Prostate Bulletin.
    In every issue of your Johns Hopkins Prostate Bulletin, you'll receive:

  • Quarterly briefings on the latest medical developments
  • Late breaking news of innovative new treatments and essential health study results
  • Expert evaluations and comparisons of new medications, surgical techniques, and diagnostic procedures
  • Authoritative medical guidance from leading experts around the world
  • At least one in-depth Special Report or update on the most important breakthroughs in prostate cancer, BPH, ED, LUTS, or prostatitis.
  • Answers to your most pressing questions about your prostate disorders in the Grand Rounds section
  • ALL delivered direct to you.

    As soon as you place your order, you will also receive your five FREE Prostate Disorders Special Reports as INSTANT PDF DOWNLOADS, so you can start using the information you learn right away in your quest for answers about your medical condition and how best to treat it.
    * Prostate Bulletin Special Report #1: BPH (Benign Prostatic Hyperplasia)
    * Prostate Bulletin Special Report #2: Diet and Prostate Health
    * Prostate Bulletin Special Report #3: Treating Overactive Bladder
    * Prostate Bulletin Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
    * Prostate Bulletin Special Report #5: The Radical Prostatectomy

    Your risk-FREE subscription and 100% money-back guarantee. The Johns Hopkins Prostate Bulletin is yours to review risk-FREE. If you are not completely satisfied, simply return the Bulletin and receive a refund with no questions asked. Keep the five Prostate Disorders Special Reports just for reviewing the Bulletin.

    Only by private subscription. Don't bother looking for The Johns Hopkins Prostate Bulletin on the newsstand. It is available only by private subscription, delivered directly to you quarterly.

    Why Johns Hopkins?


  • © 2009 MediZine LLC. All rights reserved.
    Contact Us
    customerservice@johnshopkinshealthalerts.com